News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,236 Results
Type
Article (14758)
Company Profile (284)
Press Release (269183)
Multimedia
Podcasts (65)
Webinars (12)
Section
Business (81315)
Career Advice (161)
Deals (13741)
Drug Delivery (39)
Drug Development (52238)
Employer Resources (31)
FDA (6302)
Job Trends (5529)
News (149225)
Policy (10589)
Tag
Academia (938)
Accelerated approval (9)
Adcomms (14)
Allergies (64)
Alliances (22102)
ALS (92)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (144)
Approvals (6402)
Artificial intelligence (181)
Autoimmune disease (34)
Automation (7)
Bankruptcy (106)
Best Places to Work (4960)
BIOSECURE Act (6)
Biosimilars (68)
Biotechnology (231)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (266)
Cancer (2307)
Cardiovascular disease (183)
Career advice (142)
Career pathing (2)
CAR-T (159)
CDC (4)
Cell therapy (426)
Cervical cancer (13)
Clinical research (43827)
Collaboration (810)
Company closure (2)
Compensation (429)
Complete response letters (27)
COVID-19 (1096)
CRISPR (71)
C-suite (319)
Cystic fibrosis (94)
Data (2752)
Denatured (13)
Depression (61)
Diabetes (211)
Diagnostics (1443)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (123)
Drug pricing (37)
Drug shortages (3)
Duchenne muscular dystrophy (162)
Earnings (31911)
Editorial (21)
Employer branding (4)
Employer resources (29)
Events (51370)
Executive appointments (575)
FDA (7592)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (707)
Gene editing (138)
Generative AI (12)
Gene therapy (368)
GLP-1 (451)
Government (1183)
Grass and pollen (2)
Guidances (150)
Healthcare (6884)
HIV (18)
Huntington's disease (30)
IgA nephropathy (45)
Immunology and inflammation (137)
Immuno-oncology (8)
Indications (32)
Infectious disease (1180)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (28)
Intellectual property (114)
Interviews (19)
IPO (7647)
IRA (13)
Job creations (889)
Job search strategy (131)
Kidney cancer (8)
Labor market (15)
Layoffs (232)
Leadership (5)
Legal (1443)
Liver cancer (42)
Longevity (9)
Lung cancer (344)
Lymphoma (169)
Machine learning (14)
Management (7)
Manufacturing (246)
MASH (88)
Medical device (2884)
Medtech (2888)
Mergers & acquisitions (6566)
Metabolic disorders (557)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (119)
Neuropsychiatric disorders (35)
Neuroscience (1609)
NextGen: Class of 2025 (2093)
Non-profit (966)
Now hiring (26)
Obesity (255)
Opinion (111)
Ovarian cancer (93)
Pain (73)
Pancreatic cancer (106)
Parkinson's disease (165)
Partnered (9)
Patents (221)
Patient recruitment (182)
Peanut (40)
People (26448)
Pharmaceutical (46)
Pharmacy benefit managers (5)
Phase I (15090)
Phase II (20064)
Phase III (13344)
Pipeline (1632)
Policy (77)
Postmarket research (1004)
Preclinical (6378)
Press Release (35)
Prostate cancer (107)
Psychedelics (44)
Radiopharmaceuticals (222)
Rare diseases (416)
Real estate (1457)
Recruiting (12)
Regulatory (9674)
Reports (19)
Research institute (978)
Resumes & cover letters (20)
Rett syndrome (10)
RNA editing (15)
RSV (14)
Schizophrenia (96)
Series A (131)
Series B (95)
Service/supplier (1)
Sickle cell disease (56)
Special edition (15)
Spinal muscular atrophy (118)
Sponsored (16)
Startups (1996)
State (1)
Stomach cancer (6)
Supply chain (28)
Tariffs (16)
The Weekly (51)
Vaccines (302)
Venture capital (44)
Weight loss (137)
Women's health (18)
Worklife (2)
Date
Today (73)
Last 7 days (282)
Last 30 days (1388)
Last 365 days (19253)
2025 (13446)
2024 (21222)
2023 (23128)
2022 (27582)
2021 (28757)
2020 (24241)
2019 (16930)
2018 (12356)
2017 (14273)
2016 (12303)
2015 (14844)
2014 (10723)
2013 (7730)
2012 (7764)
2011 (7880)
2010 (7634)
Location
Africa (155)
Alabama (57)
Alaska (2)
Arizona (61)
Arkansas (5)
Asia (18111)
Australia (3067)
California (5494)
Canada (1535)
China (560)
Colorado (202)
Connecticut (216)
Delaware (180)
Europe (39588)
Florida (692)
Georgia (181)
Hawaii (2)
Idaho (16)
Illinois (324)
India (20)
Indiana (150)
Iowa (7)
Japan (165)
Kansas (72)
Kentucky (7)
Louisiana (4)
Maine (12)
Maryland (606)
Massachusetts (4379)
Michigan (91)
Minnesota (210)
Mississippi (3)
Missouri (32)
Montana (14)
Nebraska (4)
Nevada (34)
New Hampshire (15)
New Jersey (1590)
New Mexico (12)
New York (1437)
North Carolina (737)
North Dakota (6)
Northern California (2534)
Ohio (148)
Oklahoma (10)
Oregon (21)
Pennsylvania (1028)
Puerto Rico (7)
Rhode Island (24)
South America (220)
South Carolina (6)
Southern California (2136)
Tennessee (34)
Texas (708)
United States (18919)
Utah (78)
Virginia (116)
Washington D.C. (38)
Washington State (465)
West Virginia (1)
Wisconsin (32)
284,236 Results for "c3j therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Silence Therapeutics to Participate in September 2025 Investor Conferences
September 3, 2025
·
1 min read
Press Releases
Whitehawk Therapeutics to Participate in Upcoming September 2025 Investor Conferences
September 3, 2025
·
1 min read
Press Releases
Avalo Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
Press Releases
Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025
August 26, 2025
·
2 min read
Press Releases
Aquestive Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 26, 2025
·
3 min read
Press Releases
Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo™ (SPT-320) in Healthy Volunteers
September 11, 2025
·
6 min read
Press Releases
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
September 5, 2025
·
5 min read
Press Releases
Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
September 11, 2025
·
7 min read
Press Releases
EndoCyclic Therapeutics Awarded Rare NIH “Perfect 10" Grant for Endometriosis Therapeutic
September 17, 2025
·
3 min read
Press Releases
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
July 3, 2025
·
7 min read
1 of 28,424
Next
